Drug Topics
OCTOBER 20, 2024
In case you missed it, this week we had stories about medication adherence and breast cancer outcomes, new vaccines in the pipeline, independent pharmacies saying no to Medicare drug price, and more.
STAT
OCTOBER 20, 2024
Seaport Therapeutics, the startup launched earlier this year by the team behind Karuna Therapeutics, has raised another $225 million just six months after its most recent fundraising round. Seaport raised the Series B funds from General Atlantic, Foresite Capital, T. Rowe Price Associates, and other investors. The startup, which is based in Boston, is developing a new cohort of what executives hope will be faster-acting, more effective treatments for depression, anxiety, and other mental health
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
OCTOBER 20, 2024
In a study, RK-33 demonstrated positive effects against the protein DDX3, which is key in the growth of cancer cells and spreading of disease.
Fierce Healthcare
OCTOBER 20, 2024
LAS VEGAS—The Coalition for Health AI unveiled the first applied model card, completed by AI imaging company Aidoc. | The Coalition for Health AI released a draft of their AI model card, or “nutrition label” for AI, filled out with information from AI imaging company Aidoc. CHAI's work is part of ongoing efforts to ensure the responsible use of AI in healthcare.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Honest Apothecary
OCTOBER 20, 2024
One challenge that modern students of the Bible will encounter is that it presents a very different perspective on the way we should think about life. For example, the other day while scrolling through some social media accounts, I saw a post that simply said, “Maintain a very high opinion of yourself.” Clearly this insight […] The post The Bible’s Different Perspective appeared first on The Honest Apothecary.
The FDA Law Blog
OCTOBER 20, 2024
By Larry K. Houck — Eric Idle, as a body collector, immortalized the phrase, “Bring out your dead! Bring out your dead!” in the 1975 comedy classic, Monty Python and the Holy Grail. The Drug Enforcement Administration (“DEA”) would do well to update that phrase as “Bring out your meds! Bring out your meds!” to call attention to the 26th National Prescription Take Back Day.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
OCTOBER 20, 2024
Google Cloud announced its Vertex AI Search for Healthcare platform is now available for general use while also rolling out new features for its Healthcare Data Engine. | The Vertex AI Search for Healthcare tool is designed to make it faster for healthcare professionals and other employees to find critical information within health records and medical documents.
Med Ed 101
OCTOBER 20, 2024
In this 10-question psychiatric Pharmacotherapy quiz, we cover antipsychotic use and bipolar pharmacotherapy. If you are looking for a practice exam for the BCPP (Board Certified Psychiatric Pharmacist) exam, you can find that here. If you are looking for comprehensive study guides on the BCPS, BCACP, BCGP, BCMTMS, or NAPLEX exams, feel free to check […] The post Free Psychiatric Pharmacotherapy Quiz appeared first on Med Ed 101.
Fierce Healthcare
OCTOBER 20, 2024
Greg Adams, Kaiser Permanente chair and CEO, detailed Risant Health's future M&A strategy as it aims to build out value-based care.
Pharmaceutical Technology
OCTOBER 20, 2024
While adverse events (AEs) were reported for 97% of trial participants, such cases were predominantly mild to moderate.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Expert insights. Personalized for you.
76 
Let's personalize your content